G
G. Brandon Gunn
Researcher at University of Texas MD Anderson Cancer Center
Publications - 195
Citations - 5246
G. Brandon Gunn is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 35, co-authored 172 publications receiving 3784 citations. Previous affiliations of G. Brandon Gunn include University of Texas Medical Branch & University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Late dysphagia after radiotherapy‐based treatment of head and neck cancer
Katherine A. Hutcheson,Jan S. Lewin,Denise A. Barringer,Asher Lisec,G. Brandon Gunn,Michael W. Moore,F. Christopher Holsinger +6 more
TL;DR: Changing trends in head and neck cancer merit an understanding of the late effects of therapy, but few studies examine dysphagia beyond 2 years of treatment.
Journal ArticleDOI
Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy
Aaron J. Grossberg,Aaron J. Grossberg,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,Hesham Elhalawani,William C. Bennett,Kirk E. Smith,Tracy S. Nolan,Bowman Williams,Sasikarn Chamchod,J. Heukelom,J. Heukelom,Michael E. Kantor,Theodora Browne,Katherine A. Hutcheson,G. Brandon Gunn,Adam S. Garden,William H. Morrison,Steven J. Frank,David I. Rosenthal,John Freymann,Clifton D. Fuller +21 more
TL;DR: In the original version of the Data Descriptor the surname of author Hesham Elhalawani was misspelled and this has now been corrected in the HTML and PDF versions.
Journal ArticleDOI
Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
Aaron J. Grossberg,Sasikarn Chamchod,Clifton D. Fuller,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,J. Heukelom,Hillary Eichelberger,Michael E. Kantor,Katherine A. Hutcheson,G. Brandon Gunn,Adam S. Garden,Steven J. Frank,Jack Phan,Beth M. Beadle,Heath D. Skinner,William H. Morrison,David I. Rosenthal +16 more
TL;DR: Diminished SM mass assessed by CT imaging or BMI can predict oncologic outcomes for patients with HNSCC, whereas weight loss after RT initiation does not predict SM loss or survival.
Journal ArticleDOI
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysis
Pierre Blanchard,Pierre Blanchard,Adam S. Garden,G. Brandon Gunn,David I. Rosenthal,William H. Morrison,Mike Hernandez,Joseph Crutison,Jack Lee,Rong Ye,C. David Fuller,C. David Fuller,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,Katherine A. Hutcheson,Emma B. Holliday,Nikhil G. Thaker,Erich M. Sturgis,Merrill S. Kies,X. Ronald Zhu,Radhe Mohan,Steven J. Frank +21 more
TL;DR: It is suggested that IMPT is associated with reduced rates of feeding tube dependency and severe weight loss without jeopardizing outcome and Prospective multicenter randomized trials are needed to validate such findings.
Journal ArticleDOI
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
Priyanka C. Iyer,Ramona Dadu,Maria Gule-Monroe,Naifa L. Busaidy,Renata Ferrarotto,Mouhammed Amir Habra,Mark Zafereo,Michelle D. Williams,G. Brandon Gunn,Horiana B. Grosu,Heath D. Skinner,Erich M. Sturgis,Neil D. Gross,Maria E. Cabanillas +13 more
TL;DR: In a subset of ATC patients, pembrolizumab may be an effective salvage therapy added to kinase inhibitors at the time of progression on these drugs, however, better treatment strategies aimed at incorporating immunotherapy in patients with ATC should be explored.